Skip to Main Content


Ventricular arrhythmias occur commonly in clinical practice and range from benign asymptomatic premature ventricular complexes (PVCs) to ventricular fibrillation (VF) resulting in sudden death. The presence of structural heart disease plays a major role in risk stratification; however, it is important to recognize potentially lethal arrhythmias that may occur in structurally normal-appearing hearts. In general, management depends on the associated symptoms, hemodynamic consequences, and associated long-term prognosis. Initial management, risk stratification, and treatment of ventricular arrhythmias pose a significant challenge to clinicians. This chapter provides an overview of the clinical presentation, natural history, diagnosis, and therapeutic options for the ventricular arrhythmias encountered in clinical practice.


Care has been taken to incorporate the American College of Cardiology/American Heart Association/European Society of Cardiology (ACC/AHA/ESC) 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death and the ACC/AHA/Heart Rhythm Society (HRS) 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities.1,2 As with all ACC/AHA guidelines, these documents provide specific categories of recommendation, according to the level of evidence available (Table 42–1).

Table Graphic Jump Location
Table 42–1. Classification of Recommendations and Levels of Evidence to Support Them

PVCs are commonly seen in clinical practice. The significance of PVCs depends on the frequency of PVCs, the presence and severity of structural heart disease, and the presence of associated symptoms.


PVCs in the Absence of Organic Heart Disease


PVCs occur frequently in the general population.3 In general, PVCs that occur in patients without structural heart disease are not associated with excess risk of sudden death. Kennedy and coworkers4 studied 73 patients with frequent ventricular ectopy and no structural heart disease on a 24-hour ambulatory (Holter) monitor. Patients were followed for an average of 6.5 years with no excess in mortality. PVCs that occur in patients with a structurally normal heart warrant no therapy, unless significant symptoms are present.


PVCs after Myocardial Infarction


Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessCardiology Full Site: One-Year Subscription

Connect to the full suite of AccessCardiology content and resources including textbooks such as Hurst's the Heart and Cardiology Clinical Questions, a unique library of multimedia, including heart imaging, an integrated drug database, and more.

$595 USD
Buy Now

Pay Per View: Timed Access to all of AccessCardiology

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.